## Abstract Dementia is common in patients with Parkinson's disease (PDD). The etiology of PDD is still unclear, but exciting advances have been made in discovering pathogenetic components in Parkinson's disease (PD), implicating the role of genetic factors. It is, however, still controversial whet
✦ LIBER ✦
Parkinson’s disease II: longitudinal progression, development of dementia and new gene therapy
✍ Scribed by Michael Strupp
- Book ID
- 106094715
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 128 KB
- Volume
- 257
- Category
- Article
- ISSN
- 0340-5354
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Associations between family history of P
✍
Martin Wilhelm Kurz; Jan Petter Larsen; Jan Terje Kvaloy; Dag Aarsland
📂
Article
📅
2006
🏛
John Wiley and Sons
🌐
English
⚖ 81 KB
👁 1 views
Future of cell and gene therapies for Pa
✍
Ole Isacson; Jeffrey H. Kordower
📂
Article
📅
2009
🏛
John Wiley and Sons
🌐
English
⚖ 146 KB
👁 2 views
Longitudinal evaluation of cerebral morp
✍
B. Ramírez–Ruiz; M. J. Martí; E. Tolosa; D. Bartrés–Faz; Ch. Summerfield; P. Sal
📂
Article
📅
2005
🏛
Springer
🌐
English
⚖ 305 KB
Progress in the development of new treat
✍
Eliezer Masliah; Lawrence A. Hansen; Edward Rockenstein; Makoto Hashimoto
📂
Article
📅
2002
🏛
John Wiley and Sons
🌐
English
⚖ 276 KB
👁 2 views
Progression of dopaminergic degeneration
✍
Walter Pirker; Schiva Djamshidian; Susanne Asenbaum; Willibald Gerschlager; Gott
📂
Article
📅
2001
🏛
John Wiley and Sons
🌐
English
⚖ 182 KB
👁 1 views
## Abstract Atypical parkinsonian syndromes (APS) such as multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration are characterized by poor response to antiparkinsonian medication and rapid clinical deterioration. We used SPECT and [^123^I]β‐CIT as a label of dopamine
Progression of dopaminergic degeneration
✍
Sean J. Colloby; E. David Williams; David J. Burn; Jim J. Lloyd; Ian G. McKeith;
📂
Article
📅
2005
🏛
Springer
🌐
English
⚖ 213 KB